AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Loss at Nabi Biopharmaceuticals deepens since losing top drug.
Byline: Stephen Pounds
Jul. 20--Losses at Nabi Biopharmaceuticals deepened in the second quarter as the company felt the full effect of losing its best-selling drug this year and deferring revenue on the sale of another drug, the company said Tuesday.
Boca Raton-based Nabi lost $21 million, or 35 cents a share, compared with a loss of almost $18 million, or 30 cents a share, for the April-through-June quarter last year. Quarterly sales were $26 million vs. $48 million. The company ended the quarter with $157 million in cash and marketable securities.
In March, Nabi lost its U.S. licensing and distribution rights for top-selling WinRho, a treatment …
-
- The Palm Beach Post, Fla., Frank Cerabino Column
-
News wire article from: The Palm Beach Post (West Palm Beach, FL)
May 31, 2012
700+ words
-
- The Palm Beach Post, Fla., Frank Cerabino column.
-
News wire article from: The Palm Beach Post (West Palm Beach, FL)
September 9, 2011
700+ words
-
- New iPad app allows you to read The Palm Beach Post on the go.
-
News wire article from: The Palm Beach Post (West Palm Beach, FL)
September 10, 2011
700+ words
-
- The Palm Beach Post, Fla., Ethan J. Skolnick Column
-
News wire article from: The Palm Beach Post (West Palm Beach, FL)
June 1, 2012
700+ words
-
- The Palm Beach Post, Fla., real estate column.
-
News wire article from: The Palm Beach Post (West Palm Beach, FL)
March 14, 2005
700+ words
